UnitedHealth Group

Healthsperien Welcomes John Mach, M.D., as Senior Advisor, Strengthening Expertise in Clinical and Value-Based Care

Retrieved on: 
Thursday, February 1, 2024

WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Healthsperien, LLC , a nationally recognized health care policy and government affairs consulting firm, proudly announces the addition of John Mach, M.D., as Senior Advisor to its team of experts.

Key Points: 
  • WASHINGTON, Feb. 1, 2024 /PRNewswire/ -- Healthsperien, LLC , a nationally recognized health care policy and government affairs consulting firm, proudly announces the addition of John Mach, M.D., as Senior Advisor to its team of experts.
  • A geriatrician and leading national expert in clinical and value-based care, Dr. Mach brings decades of business leadership and in-depth experience supporting aging populations, further enhancing Healthsperien's services for its diverse client base.
  • "John's rich background in geriatric care and research, combined with his proficiency in value-based care, makes him an invaluable asset to our team.
  • Dr. Mach has consistently achieved clinical, quality, and cost improvements for diverse populations, expertise he will bring to bear with a range of clients at Healthsperien.

United Health Products Reports on FDA Application Status

Retrieved on: 
Friday, January 19, 2024

About United Health Products -- UHP develops, manufactures and markets HemoStyp™, a patented Neutralized Regenerated Cellulose hemostatic agent. HemoStyp is an all-natural product designed to control bleeding. UHP currently offers a suite of hemostatic products to the dental, veterinary and emergency medicine markets, and is seeking approval to access the human surgical market. 

Key Points: 
  • MESQUITE, NV, Jan. 19, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products (UEEC) reports today on the receipt and review of final reports on product sterilization and stability testing for its hemostatic gauze.
  • As previously disclosed, UHP has been working with external packaging and sterilization service providers to complete various required tests for its Premarket Approval application.
  • UHP will now compile these data and proceed with final drafting of the PMA documentation to be submitted via the eSTAR platform for FDA and Health Canada review.
  • There can be no assurance that the company’s PMA or Health Canada applications will be approved.

INROADS 2024 Benefit Gala Award Recipients Embody the Dream of Dr. Martin Luther King, Jr.

Retrieved on: 
Wednesday, January 17, 2024

Presented by P&G, this year’s Benefit Gala recognizes change-agents doing breakthrough work to create a more equitable world and achieve the dream of opportunity for all.

Key Points: 
  • Presented by P&G, this year’s Benefit Gala recognizes change-agents doing breakthrough work to create a more equitable world and achieve the dream of opportunity for all.
  • “Our INROADS founder, Father Frank C. Carr, attended Dr. Martin Luther King, Jr.’s ‘I Have a Dream’ speech during the March on Washington over 60 years ago.
  • INROADS is proud to have the support of presenting sponsor Procter & Gamble for this year’s Benefit Gala.
  • To learn more about the Benefit Gala and how you can support or register, visit https://inroads.org/BenefitGala/ .

Medix Infusion Announces the Appointment of Pavlos Pavlidis, Jr., President and Chief Operating Officer

Retrieved on: 
Monday, January 29, 2024

ADDISON, Texas, Jan. 29, 2024 /PRNewswire-PRWeb/ -- As Medix Infusion's new President and COO, Pav will lead and scale the company's multi-state business operations including Nursing, Pharmacy, Procurement, Business Insights and other operational departments that support the Company's 40 locations across 5 states. Since the end of 2020 Medix has grown nearly 600%, expanded manufacturer partnerships and established itself as a leader in infusion care. "Pav brings decades of leadership and operations experience in specialty pharmacy, biotechnology, and patient support services, as well as exceptional physician and patient advocacy focus. Execution without compromising, our team culture will be essential as Medix looks to continue to grow as a national leader, and Pav has an impressive history of developing efficiencies while developing, coaching, and successfully impacting organizational culture. We are delighted to have someone of Pav's caliber and reputation join our mission, and we look forward to his contributions in the next phase of the Company's growth," said CEO Gus de Avillez.

Key Points: 
  • Medix Infusion, a leader in the infusion industry, announced that Pavlos "Pav" Pavlidis has been appointed Medix's new President and Chief Operating Officer.
  • Since the end of 2020 Medix has grown nearly 600%, expanded manufacturer partnerships and established itself as a leader in infusion care.
  • Prior to joining Medix Infusion, Pav served as Chief Operating Officer at Biologics by McKesson.
  • Pav had many other notable leadership roles, including President & Chief Operating Officer at AppianRx, VP at UnitedHealth Group, Sr. Director at Biogen, VP and General Manager at Medco.

Napoli Shkolnik 2023 In Review: Law Firm Reaches Groundbreaking Victories for Victims of Water Contamination; Important Litigation Filed in Insulin Pricing Scheme, Air Pollution, and More

Retrieved on: 
Wednesday, January 24, 2024

National law firm Napoli Shkolnik has concluded another successful year of landmark settlements and significant legal action in the areas of environmental litigation, mass tort, and human rights.

Key Points: 
  • National law firm Napoli Shkolnik has concluded another successful year of landmark settlements and significant legal action in the areas of environmental litigation, mass tort, and human rights.
  • Among the firm’s accomplishments of 2023 were significant breakthroughs in the ongoing multidistrict litigation (MDL) against manufacturers of aqueous film-forming foam (AFFF).
  • The funds will go to cities, towns and other public water providers over a 13-year period to test for and treat PFAS contamination.
  • The program’s rigorous and enriching curriculum is designed to continue Napoli Shkolnik’s legacy of delivering justice for their clients.

ON24 Recognizes 2023’s Leaders in Digital Engagement

Retrieved on: 
Thursday, January 18, 2024

“At ON24, our goal is to propel business success through digital engagement, with our customers at the core.

Key Points: 
  • “At ON24, our goal is to propel business success through digital engagement, with our customers at the core.
  • S&P Global doubled marketing qualified leads and boosted engagement by designing an ON24 digital experience personalized to different customer segments.
  • UnitedHealthcare achieved an 80% cost savings, increased attendee score and engagement with a new digital engagement strategy and an always-on content hub.
  • To learn more about 2023’s leaders in digital engagement, watch the on-demand webinar here .

UpStream Appoints John Way as Chief Financial Officer

Retrieved on: 
Thursday, January 18, 2024

GREENSBORO, N.C., Jan. 18, 2024 /PRNewswire/ -- UpStream, a leader in managed services for senior healthcare, proudly announces the appointment of John Way as Chief Financial Officer, effective January 2nd. John Way, known for his vast experience in financial leadership across various industries, is set to drive UpStream's strategic financial initiatives, reinforcing the company's commitment to excellence in the senior healthcare sector.

Key Points: 
  • GREENSBORO, N.C., Jan. 18, 2024 /PRNewswire/ -- UpStream, a leader in managed services for senior healthcare, proudly announces the appointment of John Way as Chief Financial Officer, effective January 2nd.
  • John Way, known for his vast experience in financial leadership across various industries, is set to drive UpStream's strategic financial initiatives, reinforcing the company's commitment to excellence in the senior healthcare sector.
  • Lankford Wade, CEO of UpStream, stated, "We are excited to have John Way join us.
  • As John Way assumes his new responsibilities, UpStream acknowledges the substantial contributions of Brendan Shanahan, the outgoing CFO.

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Retrieved on: 
Wednesday, January 17, 2024

Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund

Key Points: 
  • Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Media release of January 15, 2024
    Investing in the future of the healthcare industry: Bellevue launches innovative AI Health Fund
    Generative Artificial Intelligence (GenAI) is bringing about an unprecedented technological transformation.
  • “The investment approach we are taking with the Bellevue AI Health (Lux) Fund that was launched on November 30, 2023 is different.
  • Healthcare will benefit greatly from GenAI,” says Co-Portfolio Manager Stefan Blum, which explains the rationale behind the launch of Bellevue Asset Management's latest healthcare fund.
  • The IT-related risks of implementing AI in healthcare are more calculable than in other industries because healthcare is such a highly regulated market.

UnitedHealth Group Reports 2023 Results

Retrieved on: 
Friday, January 12, 2024

UnitedHealth Group’s 2023 revenues grew $47.5 billion or 14.6% year-over-year to $371.6 billion, including double-digit growth at both Optum and UnitedHealthcare, driven by serving more people, more comprehensively across its offerings.

Key Points: 
  • UnitedHealth Group’s 2023 revenues grew $47.5 billion or 14.6% year-over-year to $371.6 billion, including double-digit growth at both Optum and UnitedHealthcare, driven by serving more people, more comprehensively across its offerings.
  • Full year 2023 earnings from operations were $32.4 billion, an increase of 13.8%.
  • Days claims payable of 47.9 compared to 49.9 at year end 2022 and 50.7 in the third quarter 2023.
  • Medical reserve development was $840 million favorable for full year 2023 and $100 million unfavorable in the fourth quarter.

Envision Healthcare Appoints Full Board of Directors to Support Next Chapter of Growth

Retrieved on: 
Thursday, January 11, 2024

Envision Healthcare, a leading national medical group, announced today the full appointment of its board of directors.

Key Points: 
  • Envision Healthcare, a leading national medical group, announced today the full appointment of its board of directors.
  • As Envision enters this next chapter, it remains focused on serving as a trusted provider of quality patient care and improving the health of communities.
  • Five directors join Steve Nelson and Henry Howe, who were recently appointed Chair of the Board of Directors, and Interim Chief Executive Officer (CEO) of Envision and Board Director, respectively, to complete the seven-member team.
  • “It is an honor to have such a talented and experienced group of healthcare leaders join our board,” Nelson said.